vs
BRINKER INTERNATIONAL, INC（EAT）与EXACT SCIENCES CORP（EXAS）财务数据对比。点击上方公司名可切换其他公司
BRINKER INTERNATIONAL, INC的季度营收约是EXACT SCIENCES CORP的1.7倍（$1.5B vs $878.4M），BRINKER INTERNATIONAL, INC净利率更高（8.8% vs -9.8%，领先18.6%），EXACT SCIENCES CORP同比增速更快（23.1% vs 6.9%），BRINKER INTERNATIONAL, INC自由现金流更多（$155.2M vs $120.4M），过去两年EXACT SCIENCES CORP的营收复合增速更高（17.4% vs 13.9%）
Brinker International, Inc.是美国跨国餐饮企业，成立于1975年，总部位于得克萨斯州达拉斯，旗下拥有Chili's和Maggiano's Little Italy两大知名连锁餐饮品牌，目前在全球持有、运营或特许经营的上述品牌门店总计达1672家。
Exact Sciences是总部位于美国威斯康星州麦迪逊的分子诊断企业，专注于早期癌症检测领域。公司核心产品覆盖结直肠癌筛查与预防场景，其中Cologuard是全球首个获批的结直肠癌粪便DNA检测产品，同时还提供其他多种癌症的筛查服务及精准肿瘤检测解决方案。
EAT vs EXAS — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $878.4M |
| 净利润 | $128.5M | $-86.0M |
| 毛利率 | — | 70.1% |
| 营业利润率 | 11.6% | -9.4% |
| 净利率 | 8.8% | -9.8% |
| 营收同比 | 6.9% | 23.1% |
| 净利润同比 | 8.4% | 90.1% |
| 每股收益（稀释后） | $2.86 | $-0.45 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.5B | $878.4M | ||
| Q3 25 | $1.3B | $850.7M | ||
| Q2 25 | $1.5B | $811.1M | ||
| Q1 25 | $1.4B | $706.8M | ||
| Q4 24 | $1.4B | $713.4M | ||
| Q3 24 | $1.1B | $708.7M | ||
| Q2 24 | $1.2B | $699.3M | ||
| Q1 24 | $1.1B | $637.5M |
| Q4 25 | $128.5M | $-86.0M | ||
| Q3 25 | $99.5M | $-19.6M | ||
| Q2 25 | $107.0M | $-1.2M | ||
| Q1 25 | $119.1M | $-101.2M | ||
| Q4 24 | $118.5M | $-864.6M | ||
| Q3 24 | $38.5M | $-38.2M | ||
| Q2 24 | $57.3M | $-15.8M | ||
| Q1 24 | $48.7M | $-110.2M |
| Q4 25 | — | 70.1% | ||
| Q3 25 | — | 68.6% | ||
| Q2 25 | — | 69.3% | ||
| Q1 25 | — | 70.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 69.4% | ||
| Q2 24 | — | 69.8% | ||
| Q1 24 | — | 70.0% |
| Q4 25 | 11.6% | -9.4% | ||
| Q3 25 | 8.7% | -3.0% | ||
| Q2 25 | 9.8% | -0.3% | ||
| Q1 25 | 11.0% | -13.6% | ||
| Q4 24 | 11.5% | -122.8% | ||
| Q3 24 | 5.0% | -5.6% | ||
| Q2 24 | 6.1% | -3.8% | ||
| Q1 24 | 6.2% | -16.7% |
| Q4 25 | 8.8% | -9.8% | ||
| Q3 25 | 7.4% | -2.3% | ||
| Q2 25 | 7.3% | -0.1% | ||
| Q1 25 | 8.4% | -14.3% | ||
| Q4 24 | 8.7% | -121.2% | ||
| Q3 24 | 3.4% | -5.4% | ||
| Q2 24 | 4.7% | -2.3% | ||
| Q1 24 | 4.3% | -17.3% |
| Q4 25 | $2.86 | $-0.45 | ||
| Q3 25 | $2.17 | $-0.10 | ||
| Q2 25 | $2.31 | $-0.01 | ||
| Q1 25 | $2.56 | $-0.54 | ||
| Q4 24 | $2.61 | $-4.69 | ||
| Q3 24 | $0.84 | $-0.21 | ||
| Q2 24 | $1.22 | $-0.09 | ||
| Q1 24 | $1.08 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.0M | $964.7M |
| 总债务越低越好 | $451.3M | — |
| 股东权益账面价值 | $379.3M | $2.4B |
| 总资产 | $2.7B | $5.9B |
| 负债/权益比越低杠杆越低 | 1.19× | — |
8季度趋势，按日历期对齐
| Q4 25 | $15.0M | $964.7M | ||
| Q3 25 | $33.6M | $1.0B | ||
| Q2 25 | $18.9M | $858.4M | ||
| Q1 25 | $17.5M | $786.2M | ||
| Q4 24 | $14.8M | $1.0B | ||
| Q3 24 | $16.2M | $1.0B | ||
| Q2 24 | $64.6M | $946.8M | ||
| Q1 24 | $15.5M | $652.1M |
| Q4 25 | $451.3M | — | ||
| Q3 25 | $525.8M | — | ||
| Q2 25 | $426.0M | — | ||
| Q1 25 | $518.3M | — | ||
| Q4 24 | $652.0M | — | ||
| Q3 24 | $806.9M | — | ||
| Q2 24 | $786.3M | — | ||
| Q1 24 | $818.5M | — |
| Q4 25 | $379.3M | $2.4B | ||
| Q3 25 | $343.9M | $2.5B | ||
| Q2 25 | $370.9M | $2.5B | ||
| Q1 25 | $259.0M | $2.4B | ||
| Q4 24 | $131.5M | $2.4B | ||
| Q3 24 | $12.7M | $3.2B | ||
| Q2 24 | $39.4M | $3.2B | ||
| Q1 24 | $-46.7M | $3.1B |
| Q4 25 | $2.7B | $5.9B | ||
| Q3 25 | $2.7B | $5.9B | ||
| Q2 25 | $2.7B | $5.8B | ||
| Q1 25 | $2.6B | $5.7B | ||
| Q4 24 | $2.6B | $5.9B | ||
| Q3 24 | $2.5B | $6.7B | ||
| Q2 24 | $2.6B | $6.7B | ||
| Q1 24 | $2.5B | $6.4B |
| Q4 25 | 1.19× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.15× | — | ||
| Q1 25 | 2.00× | — | ||
| Q4 24 | 4.96× | — | ||
| Q3 24 | 63.54× | — | ||
| Q2 24 | 19.96× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $218.9M | $151.7M |
| 自由现金流经营现金流 - 资本支出 | $155.2M | $120.4M |
| 自由现金流率自由现金流/营收 | 10.7% | 13.7% |
| 资本支出强度资本支出/营收 | 4.4% | 3.6% |
| 现金转化率经营现金流/净利润 | 1.70× | — |
| 过去12个月自由现金流最近4个季度 | $455.9M | $356.8M |
8季度趋势，按日历期对齐
| Q4 25 | $218.9M | $151.7M | ||
| Q3 25 | $120.8M | $219.9M | ||
| Q2 25 | $186.0M | $89.0M | ||
| Q1 25 | $212.0M | $30.8M | ||
| Q4 24 | $218.2M | $47.1M | ||
| Q3 24 | $62.8M | $138.7M | ||
| Q2 24 | $141.5M | $107.1M | ||
| Q1 24 | $130.1M | $-82.3M |
| Q4 25 | $155.2M | $120.4M | ||
| Q3 25 | $62.2M | $190.0M | ||
| Q2 25 | $106.1M | $46.7M | ||
| Q1 25 | $132.4M | $-365.0K | ||
| Q4 24 | $168.9M | $10.7M | ||
| Q3 24 | $6.3M | $112.6M | ||
| Q2 24 | $83.5M | $71.2M | ||
| Q1 24 | $78.7M | $-120.0M |
| Q4 25 | 10.7% | 13.7% | ||
| Q3 25 | 4.6% | 22.3% | ||
| Q2 25 | 7.3% | 5.8% | ||
| Q1 25 | 9.3% | -0.1% | ||
| Q4 24 | 12.4% | 1.5% | ||
| Q3 24 | 0.6% | 15.9% | ||
| Q2 24 | 6.9% | 10.2% | ||
| Q1 24 | 7.0% | -18.8% |
| Q4 25 | 4.4% | 3.6% | ||
| Q3 25 | 4.3% | 3.5% | ||
| Q2 25 | 5.5% | 5.2% | ||
| Q1 25 | 5.6% | 4.4% | ||
| Q4 24 | 3.6% | 5.1% | ||
| Q3 24 | 5.0% | 3.7% | ||
| Q2 24 | 4.8% | 5.1% | ||
| Q1 24 | 4.6% | 5.9% |
| Q4 25 | 1.70× | — | ||
| Q3 25 | 1.21× | — | ||
| Q2 25 | 1.74× | — | ||
| Q1 25 | 1.78× | — | ||
| Q4 24 | 1.84× | — | ||
| Q3 24 | 1.63× | — | ||
| Q2 24 | 2.47× | — | ||
| Q1 24 | 2.67× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EAT
| Chilis Restaurants | $1.3B | 91% |
| Maggianos Restaurants | $134.9M | 9% |
| Franchise Revenues | $13.4M | 1% |
EXAS
| Screening | $695.1M | 79% |
| Precision Oncology | $183.2M | 21% |
